Fernando Moura

Av Albert Einstein 627
Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Landscape of clinical trials and impact of precision medicine in biliary tract cancers in the last 45 years: a systematic review and meta-analysis of biomarker-driven trials.

Landscape of clinical trials and impact of precision medicine in biliary tract cancers in the last 45 years: a systematic review and meta-analysis of biomarker-driven trials.

Journal: Translational gastroenterology and hepatology

Published: February 07, 2026

Very High vs. High Tumor Mutational Burden Across Tumors: Real-World Associations with MSI, Pathway Features, and Immunotherapy Outcomes.

Very High vs. High Tumor Mutational Burden Across Tumors: Real-World Associations with MSI, Pathway Features, and Immunotherapy Outcomes.

Journal: Biomedicines

Published: January 26, 2026

Disparities in disease profiles among Afro-Brazilians and public healthcare patients with prostate cancer: real-world data from Brazil.

Disparities in disease profiles among Afro-Brazilians and public healthcare patients with prostate cancer: real-world data from Brazil.

Journal: Einstein (Sao Paulo, Brazil)

Published: November 10, 2025

Efficacy and safety signals from early-phase studies of KRAS inhibition in pancreatic cancer.

Efficacy and safety signals from early-phase studies of KRAS inhibition in pancreatic cancer.

Journal: Scientific reports

Published: October 13, 2025

Access Barriers to Pembrolizumab in Brazil.

Access Barriers to Pembrolizumab in Brazil.

Journal: JAMA network open

Published: August 22, 2025

Real-world genomic profiling of solid tumors: validation and clinical insights from a Brazilian cohort.

Real-world genomic profiling of solid tumors: validation and clinical insights from a Brazilian cohort.

Journal: Einstein (Sao Paulo, Brazil)

Published: July 11, 2025

Immune checkpoint inhibitors combined with tyrosine kinase inhibitors for soft-tissue sarcomas: a systematic review and single-arm meta-analysis.

Immune checkpoint inhibitors combined with tyrosine kinase inhibitors for soft-tissue sarcomas: a systematic review and single-arm meta-analysis.

Journal: The oncologist

Published: May 26, 2025

Pathologic Responses to Stereotactic Ablative Radiotherapy in Combination With Nivolumab for Early Stage NSCLC: A Phase 2 Study.

Pathologic Responses to Stereotactic Ablative Radiotherapy in Combination With Nivolumab for Early Stage NSCLC: A Phase 2 Study.

Journal: JTO clinical and research reports

Published: April 28, 2025

Outcomes of multiple myeloma in patients with access to novel drugs.

Outcomes of multiple myeloma in patients with access to novel drugs.

Journal: Einstein (Sao Paulo, Brazil)

Published: April 03, 2025

Response to trastuzumab-deruxtecan in metastatic triple-negative breast cancer with both HER2 mutation and low expression.

Response to trastuzumab-deruxtecan in metastatic triple-negative breast cancer with both HER2 mutation and low expression.

Journal: Einstein (Sao Paulo, Brazil)

Published: March 25, 2025

Microsatellite Instability and Clinical Use in Sarcomas: Systematic Review and Illustrative Case Report.

Microsatellite Instability and Clinical Use in Sarcomas: Systematic Review and Illustrative Case Report.

Journal: JCO precision oncology

Published: October 21, 2024

Frequency of Deleterious Germline Variants in HER2-Low Breast Cancer Patients Using a Hereditary Multipanel Gene Testing.

Frequency of Deleterious Germline Variants in HER2-Low Breast Cancer Patients Using a Hereditary Multipanel Gene Testing.

Journal: Current issues in molecular biology

Published: July 14, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026